• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PubChem 生物测定:迈向开放高通量筛选数据共享的十年发展。

PubChem BioAssay: A Decade's Development toward Open High-Throughput Screening Data Sharing.

机构信息

1 National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, MD, USA.

出版信息

SLAS Discov. 2017 Jul;22(6):655-666. doi: 10.1177/2472555216685069. Epub 2017 Jan 13.

DOI:10.1177/2472555216685069
PMID:28346087
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5480605/
Abstract

High-throughput screening (HTS) is now routinely conducted for drug discovery by both pharmaceutical companies and screening centers at academic institutions and universities. Rapid advance in assay development, robot automation, and computer technology has led to the generation of terabytes of data in screening laboratories. Despite the technology development toward HTS productivity, fewer efforts were devoted to HTS data integration and sharing. As a result, the huge amount of HTS data was rarely made available to the public. To fill this gap, the PubChem BioAssay database ( https://www.ncbi.nlm.nih.gov/pcassay/ ) was set up in 2004 to provide open access to the screening results tested on chemicals and RNAi reagents. With more than 10 years' development and contributions from the community, PubChem has now become the largest public repository for chemical structures and biological data, which provides an information platform to worldwide researchers supporting drug development, medicinal chemistry study, and chemical biology research. This work presents a review of the HTS data content in the PubChem BioAssay database and the progress of data deposition to stimulate knowledge discovery and data sharing. It also provides a description of the database's data standard and basic utilities facilitating information access and use for new users.

摘要

高通量筛选(HTS)现在已成为制药公司和学术机构及大学筛选中心进行药物发现的常规手段。检测方法开发、机器人自动化和计算机技术的快速进步导致筛选实验室产生了数太字节的数据。尽管在 HTS 生产力方面有技术进步,但在 HTS 数据集成和共享方面的投入较少。结果,大量的 HTS 数据很少向公众提供。为了填补这一空白,2004 年建立了 PubChem BioAssay 数据库(https://www.ncbi.nlm.nih.gov/pcassay/),以提供对化学品和 RNAi 试剂进行筛选结果的公开访问。经过 10 多年的发展和社区的贡献,PubChem 现已成为最大的公共化学结构和生物数据存储库,为支持药物开发、药物化学研究和化学生物学研究的全球研究人员提供了一个信息平台。本文综述了 PubChem BioAssay 数据库中的 HTS 数据内容和数据提交进展,以激发知识发现和数据共享。它还描述了数据库的数据标准和基本实用程序,为新用户提供了信息访问和使用的便利。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13f1/5480605/221b84bea79d/10.1177_2472555216685069-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13f1/5480605/55ad075b1115/10.1177_2472555216685069-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13f1/5480605/ff0c7337c050/10.1177_2472555216685069-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13f1/5480605/17afc664e67e/10.1177_2472555216685069-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13f1/5480605/06a0a7d01756/10.1177_2472555216685069-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13f1/5480605/221b84bea79d/10.1177_2472555216685069-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13f1/5480605/55ad075b1115/10.1177_2472555216685069-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13f1/5480605/ff0c7337c050/10.1177_2472555216685069-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13f1/5480605/17afc664e67e/10.1177_2472555216685069-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13f1/5480605/06a0a7d01756/10.1177_2472555216685069-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13f1/5480605/221b84bea79d/10.1177_2472555216685069-fig5.jpg

相似文献

1
PubChem BioAssay: A Decade's Development toward Open High-Throughput Screening Data Sharing.PubChem 生物测定:迈向开放高通量筛选数据共享的十年发展。
SLAS Discov. 2017 Jul;22(6):655-666. doi: 10.1177/2472555216685069. Epub 2017 Jan 13.
2
PubChem BioAssay: 2017 update.《PubChem生物测定:2017年更新》
Nucleic Acids Res. 2017 Jan 4;45(D1):D955-D963. doi: 10.1093/nar/gkw1118. Epub 2016 Nov 29.
3
PubChem BioAssay: 2014 update.PubChem 生物测定:2014 年更新。
Nucleic Acids Res. 2014 Jan;42(Database issue):D1075-82. doi: 10.1093/nar/gkt978. Epub 2013 Nov 5.
4
PubChem's BioAssay Database.PubChem 的生物测定数据库。
Nucleic Acids Res. 2012 Jan;40(Database issue):D400-12. doi: 10.1093/nar/gkr1132. Epub 2011 Dec 2.
5
PubChem 2019 update: improved access to chemical data.PubChem 2019 年更新:改善化学数据获取。
Nucleic Acids Res. 2019 Jan 8;47(D1):D1102-D1109. doi: 10.1093/nar/gky1033.
6
A novel method for mining highly imbalanced high-throughput screening data in PubChem.一种挖掘 PubChem 中高度不平衡高通量筛选数据的新方法。
Bioinformatics. 2009 Dec 15;25(24):3310-6. doi: 10.1093/bioinformatics/btp589. Epub 2009 Oct 13.
7
An overview of the PubChem BioAssay resource.PubChem 生物测定资源概述。
Nucleic Acids Res. 2010 Jan;38(Database issue):D255-66. doi: 10.1093/nar/gkp965. Epub 2009 Nov 19.
8
High-Throughput Screening Assay Profiling for Large Chemical Databases.高通量筛选测定大化学数据库。
Methods Mol Biol. 2022;2474:125-132. doi: 10.1007/978-1-0716-2213-1_12.
9
Formalization, annotation and analysis of diverse drug and probe screening assay datasets using the BioAssay Ontology (BAO).使用生物测定学本体(BAO)对各种药物和探针筛选分析实验数据集进行形式化、注释和分析。
PLoS One. 2012;7(11):e49198. doi: 10.1371/journal.pone.0049198. Epub 2012 Nov 14.
10
Using the BioAssay Ontology for analyzing high-throughput screening data.使用生物测定本体论分析高通量筛选数据。
J Biomol Screen. 2015 Mar;20(3):402-15. doi: 10.1177/1087057114563493. Epub 2014 Dec 15.

引用本文的文献

1
History of Biological Databases, Their Importance, and Existence in Modern Scientific and Policy Context.生物数据库的历史、其重要性以及在现代科学和政策背景下的存在情况。
Genes (Basel). 2025 Jan 18;16(1):100. doi: 10.3390/genes16010100.
2
ChemFH: an integrated tool for screening frequent false positives in chemical biology and drug discovery.ChemFH:一种用于筛选化学生物学和药物发现中常见假阳性的综合工具。
Nucleic Acids Res. 2024 Jul 5;52(W1):W439-W449. doi: 10.1093/nar/gkae424.
3
Tackling assay interference associated with small molecules.

本文引用的文献

1
PubChem BioAssay: 2017 update.《PubChem生物测定:2017年更新》
Nucleic Acids Res. 2017 Jan 4;45(D1):D955-D963. doi: 10.1093/nar/gkw1118. Epub 2016 Nov 29.
2
Analysis of the Effects of Cell Stress and Cytotoxicity on In Vitro Assay Activity Across a Diverse Chemical and Assay Space.细胞应激和细胞毒性对跨多种化学物质和检测空间的体外检测活性的影响分析
Toxicol Sci. 2016 Oct;153(2):409. doi: 10.1093/toxsci/kfw148. Epub 2016 Sep 7.
3
Getting the most out of PubChem for virtual screening.充分利用 PubChem 进行虚拟筛选。
解决小分子相关的检测干扰问题。
Nat Rev Chem. 2024 May;8(5):319-339. doi: 10.1038/s41570-024-00593-3. Epub 2024 Apr 15.
4
Identification of Novel Antimicrobial Compounds Targeting -Adenosyl-L-Homocysteine Hydrolase Using Dual Hierarchical In Silico Structure-Based Drug Screening.采用双重分层基于结构的计算机药物筛选技术,鉴定靶向 -Adenosyl-L-同型半胱氨酸水解酶的新型抗菌化合物。
Molecules. 2024 Mar 14;29(6):1303. doi: 10.3390/molecules29061303.
5
Integrating multiscale and machine learning approaches towards the SAMPL9 log  challenge.将多尺度和机器学习方法整合用于应对SAMPL9日志挑战。
Phys Chem Chem Phys. 2024 Feb 28;26(9):7907-7919. doi: 10.1039/d3cp04140a.
6
Finding information about uncharacterized Drosophila melanogaster genes.查找关于未鉴定的黑腹果蝇基因的信息。
Genetics. 2023 Dec 6;225(4). doi: 10.1093/genetics/iyad187.
7
High-Throughput Phenotypic Screening and Machine Learning Methods Enabled the Selection of Broad-Spectrum Low-Toxicity Antitrypanosomatidic Agents.高通量表型筛选和机器学习方法助力广谱低毒性抗锥虫药物的选择。
J Med Chem. 2023 Nov 23;66(22):15230-15255. doi: 10.1021/acs.jmedchem.3c01322. Epub 2023 Nov 3.
8
A practical guide to machine-learning scoring for structure-based virtual screening.基于结构的虚拟筛选的机器学习评分实用指南。
Nat Protoc. 2023 Nov;18(11):3460-3511. doi: 10.1038/s41596-023-00885-w. Epub 2023 Oct 16.
9
The Commoditization of AI for Molecule Design.用于分子设计的人工智能商品化
Artif Intell Life Sci. 2022 Dec;2. doi: 10.1016/j.ailsci.2022.100031. Epub 2022 Jan 24.
10
GenUI: interactive and extensible open source software platform for de novo molecular generation and cheminformatics.GenUI:用于从头分子生成和化学信息学的交互式可扩展开源软件平台。
J Cheminform. 2021 Sep 25;13(1):73. doi: 10.1186/s13321-021-00550-y.
Expert Opin Drug Discov. 2016 Sep;11(9):843-55. doi: 10.1080/17460441.2016.1216967. Epub 2016 Aug 5.
4
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.一种用于鉴定阻断范可尼贫血DNA修复途径的蛋白质-蛋白质相互作用抑制剂的高通量筛选策略。
J Biomol Screen. 2016 Jul;21(6):626-33. doi: 10.1177/1087057116635503. Epub 2016 Mar 8.
5
Public Domain HTS Fingerprints: Design and Evaluation of Compound Bioactivity Profiles from PubChem's Bioassay Repository.公共领域高通量筛选指纹图谱:来自PubChem生物测定数据库的化合物生物活性谱的设计与评估
J Chem Inf Model. 2016 Feb 22;56(2):390-8. doi: 10.1021/acs.jcim.5b00498. Epub 2016 Jan 14.
6
BindingDB in 2015: A public database for medicinal chemistry, computational chemistry and systems pharmacology.2015年的BindingDB:一个用于药物化学、计算化学和系统药理学的公共数据库。
Nucleic Acids Res. 2016 Jan 4;44(D1):D1045-53. doi: 10.1093/nar/gkv1072. Epub 2015 Oct 19.
7
Dark chemical matter as a promising starting point for drug lead discovery.暗物质化学作为药物先导发现的有前景的起点。
Nat Chem Biol. 2015 Dec;11(12):958-66. doi: 10.1038/nchembio.1936. Epub 2015 Oct 19.
8
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.6-磷酸葡萄糖酸脱氢酶通过抑制LKB1-AMPK信号传导将氧化戊糖磷酸途径、脂肪生成和肿瘤生长联系起来。
Nat Cell Biol. 2015 Nov;17(11):1484-96. doi: 10.1038/ncb3255. Epub 2015 Oct 19.
9
The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands.《2016年IUPHAR/BPS药理学指南:迈向1300个蛋白质靶点与6000种配体之间的精准定量相互作用》
Nucleic Acids Res. 2016 Jan 4;44(D1):D1054-68. doi: 10.1093/nar/gkv1037. Epub 2015 Oct 12.
10
Mechanism Profiling of Hepatotoxicity Caused by Oxidative Stress Using Antioxidant Response Element Reporter Gene Assay Models and Big Data.使用抗氧化反应元件报告基因检测模型和大数据对氧化应激引起的肝毒性进行机制剖析
Environ Health Perspect. 2016 May;124(5):634-41. doi: 10.1289/ehp.1509763. Epub 2015 Sep 18.